-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Praxis Precision Medicine, Raises Price Target to $500

Benzinga·12/08/2025 15:37:13
Listen to the news
Truist Securities analyst Joon Lee maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $360 to $500.